Analysis of other cancer types using TCGA has shown a similar selectivity to ovarian cancer; in lung cancer or esophageal cancer, the total amplification rate was lower than that for ovarian cancer, but the missense mutation rate was higher in either UPF1 or UPF2 (Figure S8). This evidence concerns the gene UPF1 and ovarian carcinoma.